03.18.10
Atrium Innovations, Quebec City, Quebec, Canada, has purchased the assets of Trophic Canada, a manufacturer and distributor of vitamins, minerals and herbal supplements in the Canadian Health Food Store (HFS) market.
Trophic’s two brands, Trophic and Wild Rose, comprising 150 products, are sold in more than 900 specialized health food stores. The company’s annualized revenues are approximately $7.5 million.
"The acquisition of Trophic will provide Atrium with a stronger and complementary foothold and greater visibility in the Canadian market," said Pierre Fitzgibbon, Atrium's president and CEO. "Trophic's respected brands are supported by a well established access to the Health Food Store channel. The two brands' high quality products, approach to science and market positioning are a perfect fit with Atrium's DNA. We see considerable potential to grow Trophic and leverage its distribution strength by adding complementary products and by gaining direct access to the specialty retailers in the Canadian market."
Under the terms of the transaction, Atrium acquired the assets of Trophic for a total cash consideration of approximately $11 million without any forward purchase price adjustments. The acquisition is immediately accretive to earnings without factoring future revenues and operating synergies.
Trophic’s two brands, Trophic and Wild Rose, comprising 150 products, are sold in more than 900 specialized health food stores. The company’s annualized revenues are approximately $7.5 million.
"The acquisition of Trophic will provide Atrium with a stronger and complementary foothold and greater visibility in the Canadian market," said Pierre Fitzgibbon, Atrium's president and CEO. "Trophic's respected brands are supported by a well established access to the Health Food Store channel. The two brands' high quality products, approach to science and market positioning are a perfect fit with Atrium's DNA. We see considerable potential to grow Trophic and leverage its distribution strength by adding complementary products and by gaining direct access to the specialty retailers in the Canadian market."
Under the terms of the transaction, Atrium acquired the assets of Trophic for a total cash consideration of approximately $11 million without any forward purchase price adjustments. The acquisition is immediately accretive to earnings without factoring future revenues and operating synergies.
